Availability, prices, and affordability of essential medicines for cardiovascular diseases and diabetes: a multi-regional survey using the WHO/HAI methodology in Pakistan
Muhammad Uzair Ul Haq, Saima Mushtaq, Smavia Jamshed, Oshna Quddoos, Aimen Rija Tareen, Shehroz Ahmad Khan, Qadeer Ahmad, Amjad Khan, Yu Fang · 2026
Read Availability, prices, and affordability of essential medicines for cardiovascular diseases and diabetes: a multi-regional survey using the WHO/HAI methodology in Pakistan by Muhammad Uzair Ul Haq, Saima Mushtaq, Smavia Jamshed, Oshna Quddoos, Aimen Rija Tareen, Shehroz Ahmad Khan, Qadeer Ahmad, Amjad Khan, Yu Fang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471443.txt.
Description
Ul Haq and co-authors surveyed whether key heart and diabetes medicines are stocked and affordable across Pakistan, using the standard WHO and Health Action International method. Their 2026 survey covered 32 essential medicines in six study areas, including Rawalpindi, Gujranwala, and Islamabad, comparing public and private outlets.
No medicine in the government sector reached the WHO availability benchmark of 80% of facilities stocking it, though some private-sector products did. Originator brands showed up more in private outlets, at 54.6% of outlets versus 34.9% in public facilities, while lowest-price generics flipped that pattern. Insulin stood out as both scarce and expensive, a combination the authors call especially worrying for long-term diabetes care.
Catalog record
| CREATOR | Muhammad Uzair Ul Haq, Saima Mushtaq, Smavia Jamshed, Oshna Quddoos, Aimen Rija Tareen, Shehroz Ahmad Khan, Qadeer Ahmad, Amjad Khan, Yu Fang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |